Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 26 Aug 2021
AbbVie receives a positive reimbursement recommendation from the Canadian Agencies for Drugs and Technology in Health (CADTH) pan-Canadian Oncology Drug Review Expert Review Committee (pERC) for Venclexta (venetoclax) in combination with azacitidine for acute myeloid leukaemia patients
26 August 2021 - pERC recommends reimbursement of Venclexta (venetoclax) in combination with azacitidine for the treatment of newly diagnosed acute ...
Posted by Michael Wonder on 26 Aug 2021
Government eases criteria for haemophilia A drug reimbursement
26 August 2021 - The Government said it would ease the immune tolerance induction treatment criteria for haemophilia A drug ...
Posted by Michael Wonder on 26 Aug 2021
Here’s how pharmacies set drug prices, and what consumers can do to save money
26 August 2021 - Americans are having a tough time paying for medications despite bipartisan efforts to drive down prescription ...
Posted by Michael Wonder on 26 Aug 2021
ICER to assess treatments for COVID-19
26 August 2021 - Report will be subject of Midwest CEPAC meeting in April 2022; Draft Scoping Document open to public ...
Posted by Michael Wonder on 26 Aug 2021
Moderna completes submission of biologics license application to the US FDA for its COVID-19 vaccine
25 August 2021 - Final blinded analysis of Phase 3 COVE study of the Moderna COVID-19 vaccine shows 93% efficacy; ...
Posted by Michael Wonder on 26 Aug 2021
Ironwood Pharmaceuticals announces FDA approval of revised Linzess (linaclotide) label
26 August 2021 - Ironwood Pharmaceuticals today announced that the U.S. FDA approved a revised label for Linzess (linaclotide) based ...
Posted by Michael Wonder on 26 Aug 2021
Sesen Bio pulls E.U. application for FDA rejected cancer drug
26 August 2021 - Sesen Bio, a small biotech firm whose investigational cancer treatment once seemed poised for approval, said ...
Posted by Michael Wonder on 26 Aug 2021
Servier announces FDA approval of Tibsovo (ivosidenib tablets) in IDH mutated cholangiocarcinoma
25 August 2021 - TIBSOVO is the first and only targeted therapy approved for patients with previously treated IDH1-mutated cholangiocarcinoma. ...
Posted by Michael Wonder on 26 Aug 2021
CellMax Life earns FDA breakthrough device designation for colon cancer & pre-cancerous adenomas screening blood test
25 August 2021 - FirstSight now qualifies for expedited FDA review process as a blood test for detection of advanced neoplasia ...
Posted by Michael Wonder on 26 Aug 2021
Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type 2 diabetes
26 August 2021 - Approval marks an important transformation in the treatment of more than 13 million people suffering from ...
Posted by Michael Wonder on 26 Aug 2021
COVID-19 vaccine weekly safety report (26 August 2021)
26 August 2021 - To 22 August 2021, approximately 17.1 million vaccine doses have been given in Australia – 10.9 million ...
Posted by Michael Wonder on 26 Aug 2021
Pfizer and BioNTech initiate rolling submission of supplemental biologics license application to U.S. FDA for booster dose of Comirnaty in individuals 16 and older
25 August 2021 - New Phase 3 data show booster (third) dose of Comirnaty induces significant SARS-CoV-2 neutralising antibody titres and ...
Posted by Michael Wonder on 26 Aug 2021
PHARMAC seeks feedback on a biosimilar brand of adalimumab being considered for funding
26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...
Posted by Michael Wonder on 25 Aug 2021
Vertex Pharma gets approval for cystic fibrosis drug for infants in Canada
25 August 2021 - Vertex Pharmaceuticals was given approval to market its drug ivacaftor that treats children as young as ...
Posted by Michael Wonder on 25 Aug 2021
Don’t meddle with Medicare to save a budget
25 August 2021 - House Democrats this week approved a $3.5 trillion budget framework that has already passed the Senate. ...